Estepan Ian Michael — SEC insider filings

SEC reporting owner CIK 1836254. 30 insider filings on record with FilingPulse; latest filed 2026-09-08.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-12-14 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sarepta Therapeutics, Inc. (SRPT)Chief Operating Officer30—3 legs · 20,372 sh · $1,270,26263

Insider filings — Estepan Ian Michael

FiledFormIssuerReported transactionsSource
2026-09-084Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 24,799 @ $22.22EDGAR
2026-03-134Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,097 @ $17.03EDGAR
2026-03-114Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,036 @ $16.95 · Tax withholding (F): 583 @ $16.95EDGAR
2026-03-034Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 8,125 · Tax withholding (F): 3,301 @ $16.20 · Tax withholding (F): 875 @ $16.20 · Option exercise (M): 8,125 (derivative) @ $0EDGAR
2026-03-024Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 2,069 @ $13.71 · Option exercise (M): 5,381 @ $13.71 · Option exercise (M): 2,069 (derivative) @ $0 · Option exercise (M): 5,381 (derivative) @ $0EDGAR
2026-02-274Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 1,875 (derivative)EDGAR
2025-12-184Sarepta Therapeutics, Inc. (SRPT)Sale (S): 13,187 @ $22.31EDGAR
2025-09-054Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 93,875 @ $0 · Grant/award (A): 50,000 @ $0EDGAR
2025-08-064Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 6,250 (derivative) @ $0EDGAR
2025-03-114Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 5,500 · Tax withholding (F): 1,051 @ $100.13 · Tax withholding (F): 2,890 @ $100.13 · Grant/award (A): 8,276 · Option exercise (M): 5,500 (derivative) @ $0 · Grant/award (A): 16,644 (derivative) @ $0EDGAR
2025-03-104Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 17,500 · Tax withholding (F): 585 @ $103.70 · Tax withholding (F): 9,094 @ $103.70 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2025-03-064Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,370 @ $101.34EDGAR
2025-03-044Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 557 @ $103.77EDGAR
2025-02-134Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 3,500 (derivative) @ $0EDGAR
2025-01-314Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 14,267 @ $12 · Option exercise (M): 1,533 @ $12 · Tax withholding (F): 2,613 @ $117.51 · Option exercise (M): 14,267 (derivative) @ $0 · Option exercise (M): 1,533 (derivative) @ $0EDGAR
2024-12-304Sarepta Therapeutics, Inc. (SRPT)Gift (G): 250 @ $0EDGAR
2024-09-034Sarepta Therapeutics, Inc. (SRPT)Sale (S): 5,985 @ $137.36EDGAR
2024-06-254Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 6,250 · Tax withholding (F): 2,483 @ $164.64 · Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2024-03-114Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 526 @ $120.49 · Tax withholding (F): 1,035 @ $123.14EDGAR
2024-03-064Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,389 @ $125.32EDGAR
2024-03-054Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 365 @ $126.19 · Grant/award (A): 6,000 @ $0 · Sale (S): 1,200 @ $128.30 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2023-03-104Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 744 @ $153.19EDGAR
2023-03-084Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,370 @ $157.21 · Grant/award (A): 4,500 @ $0 · Grant/award (A): 27,000 (derivative) @ $0EDGAR
2023-03-034Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 378 @ $147.57EDGAR
2022-03-084Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,308 @ $79.20 · Tax withholding (F): 398 @ $79.36 · Grant/award (A): 8,000 @ $0 · Grant/award (A): 48,000 (derivative) @ $0EDGAR
2022-03-014Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 376 @ $75.05EDGAR
2021-09-094Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,623 @ $78.29EDGAR
2021-03-104/ASarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 319 @ $86.97 · Grant/award (A): 15,000 @ $0 · Tax withholding (F): 347 @ $84.65EDGAR
2021-03-054Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 15,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-12-144Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 25,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1836254 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs